Middle East: an emerging multibillion dollar medical technology market awaits
This article was originally published in Clinica
Middle Eastern countries vary in terms of political and economic stability, but this "cash rich" region is preparing to invest in multi-billion dollar projects with huge medtech potential. This was the common theme of the event "Doing Business in the Middle East", held by the Association of British Healthcare Industries, at the premises of the Middle East Association (MEA) in London yesterday.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.